Prostaglandin E2 stimulates granulocyte colony-stimulating factor production via the prostanoid EP2 receptor in mouse peritoneal neutrophils

被引:19
作者
Sugimoto, Y
Fukada, Y
Mori, D
Tanaka, S
Yamane, H
Okuno, Y
Deai, K
Tsuchiya, S
Tsujimoto, G
Ichikawa, A
机构
[1] Mukogawa Womens Univ, Sch Pharmaceut Sci, Nishinomiya, Hyogo 6638179, Japan
[2] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Physiol Chem, Kyoto, Japan
[3] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Genom Drug Discovery Sci, Kyoto, Japan
关键词
D O I
10.4049/jimmunol.175.4.2606
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
G-CSF is a hemopoietic growth factor involved in granulocytic differentiation of progenitor cells. In this study, we investigated the effects of PGE, on G-CSF production in murine peritoneal neutrophils in vitro and in vivo. PGE(2) augmented LPS-primed G-CSF release from peritoneal neutrophils. This augmentation was mimicked by a type E prostanoid receptor (EP)2-selective agonist but not by other EP-specific agonists. Indeed, the effect of PGE2 on G-CSF release was abolished in neutrophils isolated from EP2deficient mice. PGE(2) and an EP2 agonist have the ability to stimulate G-CSF gene expression even in the absence of LPS. In the casein-induced peritonitis model, the appearance of G-CSF in the casein-injected peritoneal cavity associated well with the timing of neutrophil infiltration as well as PGE(2) levels in exudates, with a peak value at 6 h postinjection. Inhibition of endogenous PG synthesis by indomethacin resulted in a marked decrease in G-CSF content and neutrophil number in the peritoneal cavity. Moreover, EP2-deficient mice exhibited a strikingly reduced G-CSF content in peritoneal exudates with comparable responses in neutrophil migration and local PGE, production at 6 h postinjection. These results suggest that the PGE(2)-EP2 system contributes to the local production of G-CSF during acute inflammation.
引用
收藏
页码:2606 / 2612
页数:7
相关论文
共 41 条
[1]   Phenotypic changes in neutrophils related to anti-inflammatory therapy [J].
Barton, AE ;
Bayley, DL ;
Mikami, M ;
Llewellyn-Jones, CG ;
Stockley, RA .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2000, 1500 (01) :108-118
[2]   Molecular aspects of anti-inflammatory action of G-CSF [J].
Boneberg, EM ;
Hartung, T .
INFLAMMATION RESEARCH, 2002, 51 (03) :119-128
[3]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[4]   THE HUMAN HEMATOPOIETIC COLONY-STIMULATING FACTORS [J].
CLARK, SC ;
KAMEN, R .
SCIENCE, 1987, 236 (4806) :1229-1237
[5]  
COLEMAN RA, 1994, PHARMACOL REV, V46, P205
[6]  
COLEMAN RA, 1990, COMPREHENSIVE MED CH, V3, P643
[7]  
DEMETRI GD, 1991, BLOOD, V78, P2791
[8]   Role of p190RhoGAP in β2 integrin regulation of RhoA in human neutrophils [J].
Dib, K ;
Melander, F ;
Andersson, T .
JOURNAL OF IMMUNOLOGY, 2001, 166 (10) :6311-6322
[9]   A molecular analysis of PGE receptor (EP) expression on normal and transformed B lymphocytes: Coexpression of EP(1), EP(2), EP(3 beta) and EP(4) [J].
Fedyk, ER ;
Ripper, JM ;
Brown, DM ;
Phipps, RP .
MOLECULAR IMMUNOLOGY, 1996, 33 (01) :33-45
[10]   Phosphorylation of glycogen synthase kinase-3 and stimulation of T-cell factor signaling following activation of EP2 and EP4 prostanoid receptors by prostaglandin E2 [J].
Fujino, H ;
West, KA ;
Regan, JW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (04) :2614-2619